Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours
Sternberg, C.N., de Mulder, P., Schornagel, J.H., Theodore, C., Fossa, S.D., van Oosterom, A.T., Witjes, J.A., Spina, M., van Groeningen, C.J., Duclos, B., Roberts, J.T., de Balincourt, C., Collette, L.
Published in European journal of cancer (1990) (2006)
Published in European journal of cancer (1990) (2006)
Get full text
Journal Article
Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group
Debiec-Rychter, M., Dumez, H., Judson, I., Wasag, B., Verweij, J., Brown, M., Dimitrijevic, S., Sciot, R., Stul, M., Vranck, H., Scurr, M., Hagemeijer, A., Van Glabbeke, M., van Oosterom, A.T.
Published in European journal of cancer (1990) (01.03.2004)
Published in European journal of cancer (1990) (01.03.2004)
Get full text
Journal Article
Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11
WILDIERS, H, GUETENS, G, DE BOECK, G, VERBEKEN, E, LANDUYT, B, LANDUYT, W, DE BRUIJN, E. A, VAN OOSTEROM, A. T
Published in British journal of cancer (16.06.2003)
Published in British journal of cancer (16.06.2003)
Get full text
Journal Article
Prevalence of methicillin-resistant Staphylococcus aureus in meat
de Boer, E., Zwartkruis-Nahuis, J.T.M., Wit, B., Huijsdens, X.W., de Neeling, A.J., Bosch, T., van Oosterom, R.A.A., Vila, A., Heuvelink, A.E.
Published in International journal of food microbiology (31.08.2009)
Published in International journal of food microbiology (31.08.2009)
Get full text
Journal Article
Conference Proceeding
Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial
LE CESNE, A, BLAY, J. Y, COLLIN, F, JIMENO, J, DI PAOLA, E, VAN GLABBEKE, M, NIELSEN, O. S, JUDSON, I, VAN OOSTEROM, A, VERWEIJ, J, RADFORD, J, LORIGAN, P, RODENHUIS, S, RAY-COQUARD, I, BONVALOT, S
Published in Journal of clinical oncology (20.01.2005)
Published in Journal of clinical oncology (20.01.2005)
Get full text
Journal Article
Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924
STERNBERG, C. N, DE MULDER, P. H. M, COLLETTE, L, SCHORNAGEL, J. H, THEODORE, C, FOSSA, S. D, VAN OOSTEROM, A. T, WITJES, F, SPINA, M, VAN GROENINGEN, C. J, DE BALINCOURT, C
Published in Journal of clinical oncology (15.05.2001)
Published in Journal of clinical oncology (15.05.2001)
Get full text
Journal Article
Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study
VAN GLABBEKE, M, VAN OOSTEROM, A. T, OOSTERHUIS, J. W, MOURIDSEN, H, CROWTHER, D, SOMERS, R, VERWEIJ, J, SANTORO, A, BUESA, J, TURSZ, T
Published in Journal of clinical oncology (01.01.1999)
Published in Journal of clinical oncology (01.01.1999)
Get full text
Journal Article
Imatinib mesylate (STI-571 Glivec®, Gleevec™) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target: Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study
Verweij, J, van Oosterom, A, Blay, J.-Y, Judson, I, Rodenhuis, S, van der Graaf, W, Radford, J, Le Cesne, A, Hogendoorn, P.C.W, di Paola, E.D, Brown, M, Nielsen, O.S
Published in European journal of cancer (1990) (01.09.2003)
Published in European journal of cancer (1990) (01.09.2003)
Get full text
Journal Article
A phase II trial with rosiglitazone in liposarcoma patients
DEBROCK, G, VANHENTENRIJK, V, SCIOT, R, DEBIEC-RYCHTER, M, OYEN, R, VAN OOSTEROM, A
Published in British journal of cancer (20.10.2003)
Published in British journal of cancer (20.10.2003)
Get full text
Journal Article
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group
Judson, I, Radford, J.A, Harris, M, Blay, J.-Y, van Hoesel, Q, le Cesne, A, van Oosterom, A.T, Clemons, M.J, Kamby, C, Hermans, C, Whittaker, J, Donato di Paola, E, Verweij, J, Nielsen, S
Published in European journal of cancer (1990) (01.05.2001)
Published in European journal of cancer (1990) (01.05.2001)
Get full text
Journal Article
Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy
Blay, J-Y, van Glabbeke, M, Verweij, J, van Oosterom, A.T, Le Cesne, A, Oosterhuis, J.W, Judson, I, Nielsen, O.S
Published in European journal of cancer (1990) (2003)
Published in European journal of cancer (1990) (2003)
Get full text
Journal Article
Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins αvβ3 and αvβ5 in patients with advanced solid tumours
Eskens, F.A.L.M, Dumez, H, Hoekstra, R, Perschl, A, Brindley, C, Böttcher, S, Wynendaele, W, Drevs, J, Verweij, J, van Oosterom, A.T
Published in European journal of cancer (1990) (01.05.2003)
Published in European journal of cancer (1990) (01.05.2003)
Get full text
Journal Article
Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients
DIRLX, L. Y, VERMEUEEN, P. B, PAWINSKI, A, PROVE, A, BENOY, I, DE POOTER, C, MARTIN, M, VAN OOSTEROM, A. T
Published in British journal of cancer (01.07.1997)
Published in British journal of cancer (01.07.1997)
Get full text
Journal Article
Phase I and pharmacokinetic study of halofuginone, an oral quinazolinone derivative in patients with advanced solid tumours
de Jonge, M.J.A., Dumez, H., Verweij, J., Yarkoni, S., Snyder, D., Lacombe, D., Marréaud, S., Yamaguchi, T., Punt, C.J.A., van Oosterom, A.
Published in European journal of cancer (1990) (01.08.2006)
Published in European journal of cancer (1990) (01.08.2006)
Get full text
Journal Article
Geometrical aspects of the interindividual variability of multilead ECG recordings
Hoekema, R., Uijen, G.J.H., van Oosterom, A.
Published in IEEE transactions on biomedical engineering (01.05.2001)
Published in IEEE transactions on biomedical engineering (01.05.2001)
Get full text
Journal Article
Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients
van Oosterom, A.T, Mouridsen, H.T, Nielsen, O.S, Dombernowsky, P, Krzemieniecki, K, Judson, I, Svancarova, L, Spooner, D, Hermans, C, Van Glabbeke, M, Verweij, J
Published in European journal of cancer (1990) (01.12.2002)
Published in European journal of cancer (1990) (01.12.2002)
Get full text
Journal Article
Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer
Bruno, R, Hille, D, Riva, A, Vivier, N, ten Bokkel Huinnink, W W, van Oosterom, A T, Kaye, S B, Verweij, J, Fossella, F V, Valero, V, Rigas, J R, Seidman, A D, Chevallier, B, Fumoleau, P, Burris, H A, Ravdin, P M, Sheiner, L B
Published in Journal of clinical oncology (01.01.1998)
Published in Journal of clinical oncology (01.01.1998)
Get more information
Journal Article